Nasal administration of a novel recombinant human parathyroid hormone (1–34) analog for the treatment of osteoporosis of ovariectomized rats
-
Add time:09/03/2019 Source:sciencedirect.com
Synthetic human parathyroid (1–34) (hPTH (1–34)) is known to have the full biological activity of the holohormone for osteoporosis. This study is about designing a novel analog of hPTH (1–34) which is more suitable for intranasal administration. We likewise evaluate effectiveness of the nasal drops against osteoroporosis. Through fusion expression of combining gene, cell disruption, inclusion body washing, ethanol fraction precipitation, acid hydrolysis, and CM-52 ion exchange column chromatography Pro-Pro-[Arg11] hPTH (1–34)-Pro-Pro was designed and produced. Nasal drops of Pro-Pro-[Arg11] hPTH (1–34)-Pro-Pro were prepared and administrated to ovariectomized rats. After 12 weeks of raising, Bone Material Densities (BMD) of vertebrae were examined by Dual Energy X-Ray Absorptiometry (DEXA). The average BMD of these groups treated with nasal drops of the peptide were 28.0%–47.2% (P < 0.01) higher than that of the group treated with normal saline (NS). The subchondral bone plates of the femoral heads were examined by scanning electron microscopy and a defined planar section was photographed. Percentage of the area of the cancellous bone was calculated. Percentages of the groups treated with nasal drops of the peptide increased; values were significantly different to that of the group treated with NS (P < 0.001) and were even equivalent to that of normal groups. These results show that nasal drops of Pro-Pro-[Arg11] hPTH (1–34)-Pro-Pro are effective against osteoporosis.
► 4PPTH is expressed in the form of a fusion protein. ► N-terminal and C-terminal Pro-Pro extension of Pro-Pro-[Arg11] hPTH (1–34)-Pro-Pro were added to protect against hydrolyzation by some proteases. ► N-terminal Pro-Pro can be set free to perform its bioactivity by DPPIV in serum. ► The substitution (Leu (11) → Arg) makes 4PPTH more potent.
We also recommend Trading Suppliers and Manufacturers of parathyroid hormone (1-34), Arg(2)- (cas 136250-66-3). Pls Click Website Link as below: cas 136250-66-3 suppliers
Prev:Parathyroid Hormone/Parathyroid Hormone-Related Protein Receptor
Next:Intermittent Fugu parathyroid hormone 1 (1–34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Binding specificity of the ectodomain of the parathyroid hormone receptor☆09/06/2019
- Chapter 2 - Parathyroid Hormone Gene: Structure, Evolution, and Regulation09/05/2019
- Intermittent Fugu parathyroid hormone 1 (1–34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats☆09/04/2019
- Parathyroid Hormone/Parathyroid Hormone-Related Protein Receptor09/02/2019
- High affinity binding of the peptide agonist TIP-39 to the parathyroid hormone 2 (PTH2) receptor requires the hydroxyl group of Tyr-318 on transmembrane helix 509/01/2019
- Molecular Mechanisms of Parathyroid Hormone Type 1 Receptor Signaling08/31/2019
- A novel human parathyroid hormone (1-34) analog for the treatment of osteoporosis08/30/2019
- A salt bridge between Arg-20 on parathyroid hormone (PTH) and Asp-137 on the PTH1 receptor is essential for full affinity08/29/2019


